Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Read more about Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting. Read more about Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Read more about A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors. Read more about Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.
Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines. Read more about Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Read more about Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
Genetic screening for oral human papillomavirus infections and cancers of the head and neck. Read more about Genetic screening for oral human papillomavirus infections and cancers of the head and neck.
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Read more about A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Read more about Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Read more about Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.
